Nasdaq Surges Over 100 Points; Apple Shares Fall After Q3 Results
Portfolio Pulse from Lisa Levin
The Nasdaq Composite gained over 100 points, with consumer discretionary shares rising by 3.6%. Apple Inc. shares fell around 2.5% despite exceeding consensus estimates for Q3 earnings and revenue, due to iPhone sales falling short of forecasts. Missfresh Limited, United States Cellular Corporation, and Telephone and Data Systems, Inc. saw significant increases in share prices, while Mesoblast Limited, Assertio Holdings, Inc., and INVO Bioscience, Inc. experienced significant drops.
August 04, 2023 | 4:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Missfresh Limited shares shot up 320% after the company announced entry of share purchase agreements for financing and business acquisition.
Missfresh's shares surged after the company announced entry of share purchase agreements for financing and business acquisition, indicating positive investor sentiment towards the company's strategic moves.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Telephone and Data Systems, Inc. shares were up, gaining 77% after the company announced the exploration of strategic alternatives for US Cellular and reported second-quarter financial results.
Telephone and Data Systems, Inc.'s shares rose after the company announced the exploration of strategic alternatives for US Cellular and reported positive Q2 results, indicating investor optimism about the company's strategic moves and performance.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Shares of United States Cellular Corporation shot up 93% following quarterly results and the announcement of the exploration of strategic alternatives.
United States Cellular Corporation's shares shot up following positive quarterly results and the announcement of the exploration of strategic alternatives, indicating strong investor confidence in the company's performance and future plans.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Apple shares fell around 2.5% despite exceeding consensus estimates for Q3 earnings and revenue, due to iPhone sales falling short of forecasts.
Despite beating consensus estimates for Q3 earnings and revenue, Apple's shares fell due to iPhone sales falling short of forecasts. This indicates that investors were expecting stronger iPhone sales.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Shares of Assertio Holdings, Inc. were down 43% after the company reported second-quarter financial results and withdrew its 2023 financial outlook to assess the recent news of a generic indomethacin suppository approved by the US FDA.
Assertio Holdings, Inc.'s shares fell after the company reported Q2 results and withdrew its 2023 financial outlook due to the FDA approval of a generic indomethacin suppository, indicating investor concerns about the company's future performance.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
INVO Bioscience, Inc. shares fell 43% after the company announced pricing of $4.5 million public offering of 1.58 million units at a price of $2.85 per unit.
INVO Bioscience, Inc.'s shares fell after the company announced the pricing of a public offering, indicating investor concerns about potential dilution of existing shares.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Mesoblast Limited shares dropped 61% after the FDA issued a complete response letter to Mesoblast’s resubmission for remestemcel-L for pediatric steroid-refractory acute graft versus host disease (SR-aGVHD), requiring more data.
Mesoblast's shares dropped significantly after the FDA required more data for the company's resubmission for remestemcel-L, indicating negative investor sentiment towards the regulatory setback.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100